Effects of flavonoid-induced oxidative stress on anti-H5N1 influenza a virus activity exerted by baicalein and biochanin A

BMC Research Notes

Volumn 7, Issue 1, 2014, Pages

  Michaelis, Martin ^a,b   Sithisarn, Patchima ^a,c   Cinatl, Jindrich ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF KENT   (United Kingdom)

^c KASETSART UNIVERSITY   (Thailand)

Author keywords

Antiviral; Baicalein; Biochanin A; H5N1; N acetyl L cysteine; Reactive oxygen species

Indexed keywords

ACETYLCYSTEINE; ANTINEOPLASTIC AGENT; ANTIOXIDANT; ANTIVIRUS AGENT; BAICALEIN; BIOCHANIN A; FLAVANONE DERIVATIVE; FLAVONOID; GENISTEIN; REACTIVE OXYGEN METABOLITE;

CELL CULTURE; DOSE RESPONSE; DRUG EFFECTS; DRUG POTENTIATION; HOST PATHOGEN INTERACTION; HUMAN; INFLUENZA VIRUS A H5N1; LUNG TUMOR; MACROPHAGE; METABOLISM; MONOCYTE; OXIDATIVE STRESS; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; VIROLOGY; VIRUS REPLICATION;

ACETYLCYSTEINE; ANTICARCINOGENIC AGENTS; ANTIOXIDANTS; ANTIVIRAL AGENTS; CELL LINE, TUMOR; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FLAVANONES; FLAVONOIDS; GENISTEIN; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; LUNG NEOPLASMS; MACROPHAGES; MONOCYTES; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; VIRUS REPLICATION;

EID: 84902738692     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-7-384     Document Type: Article

References (36)

1. Distribution of amantadine-resistant H5N1 avian influenza variants in Asia. Cheung CL, Rayner JM, Smith GJ, Wang P, Naipospos TS, Zhang J, Yuen KY, Webster RG, Peiris JS, Guan Y, Chen H, J Infect Dis 2006 193 1626 1629 10.1086/504723 16703504 (Pubitemid 43839465)
2. H5N1 transmission and disease: observations from the frontlines. de Jong MD, Pediatr Infect Dis J 2008 27 54 S56 10.1097/INF.0b013e3181684d2d 18820578
3. Human infection with highly pathogenic avian influenza virus (H5N1) in northern Vietnam, 2004-2005. Hien ND, Ha NH, Van NT, Ha NT, Lien TT, Thai NQ, Trang VD, Shimbo T, Takahashi Y, Kato Y, Kawana A, Akita S, Kudo K, Emerg Infect Dis 2009 15 19 23 10.3201/eid1501.080073 19116044
4. Reduced sensitivity of influenza A (H5N1) to oseltamivir. McKimm-Breschkin JL, Selleck PW, Usman TB, Johnson MA, Emerg Infect Dis 2007 13 1354 1357 10.3201/eid1309.070164 18252107 (Pubitemid 47510297)
5. Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide. Deyde VM, Xu X, Bright RA, Shaw M, Smith CB, Zhang Y, Shu Y, Gubareva LV, Cox NJ, Klimov AI, J Infect Dis 2007 196 249 257 10.1086/518936 17570112 (Pubitemid 47047464)
6. Vaccines for pandemic influenza. The history of our current vaccines, their limitations and the requirements to deal with a pandemic threat. Hampson AW, Ann Acad Med Singapore 2008 37 510 517 18618064
7. The pandemic influenza vaccine challenge. Kieny MP, Fukuda K, Vaccine 2008 26 Suppl 4 3 D4 19230152
8. Antiviral drugs for the control of pandemic influenza virus. Sugrue RJ, Tan BH, Yeo DS, Sutejo R, Ann Acad Med Singapore 2008 37 518 524 18618065
9. Fatal oseltamivir-resistant influenza virus infection. van der Vries E, van den Berg B, Schutten M, N Engl J Med 2008 359 1074 1076 10.1056/NEJMc0803120
10. Of chickens and men: avian influenza in humans. Michaelis M, Doerr HW, Cinatl J Jr, Curr Mol Med 2009 9 131 151 10.2174/156652409787581565 19275623
11. Global transmission of oseltamivir-resistant influenza. Moscona A, N Engl J Med 2009 360 953 956 10.1056/NEJMp0900648 19258250
12. The 2009 influenza pandemic: promising lessons for antiviral therapy for future outbreaks. Bavagnoli L, Maga G, Curr Med Chem 2011 18 5466 5475 10.2174/092986711798194397 22087838
13. Emergence and phylogenetic analysis of amantadine-resistant influenza a subtype H3N2 viruses in Dublin, Ireland, over Six Seasons from 2003/2004 to 2008/2009. Salter A, Ni LB, Crowley B, Intervirology 2011 54 305 315 10.1159/000321358 21228542
14. Advances in flavonoid research since 1992. Harborne JB, Williams CA, Phytochemistry 2000 55 481 504 10.1016/S0031-9422(00)00235-1 11130659
15. Flavonoids: a review of probable mechanisms of action and potential applications. Nijveldt RJ, van Nood E, van Hoorn DE, Boelens PG, van Norren K, van Leeuwen PA, Am J Clin Nutr 2001 74 418 425 11566638 (Pubitemid 32880250)
16. Inhibition of influenza virus replication by plant-derived isoquercetin. Kim Y, Narayanan S, Chang KO, Antiviral Res 2010 88 227 235 10.1016/j.antiviral. 2010.08.016 20826184
17. Inhibitory effects of baicalein on the influenza virus in vivo is determined by baicalin in the serum. Xu G, Dou J, Zhang L, Guo Q, Zhou C, Biol Pharm Bull 2010 33 238 243 10.1248/bpb.33.238 20118546
18. Synergistic activity of baicalein with ribavirin against influenza A (H1N1) virus infections in cell culture and in mice. Chen L, Dou J, Su Z, Zhou H, Wang H, Zhou W, Guo Q, Zhou C, Antiviral Res 2011 91 314 320 10.1016/j.antiviral.2011.07.008 21782851
19. Influenza neuraminidase: a druggable target for natural products. Grienke U, Schmidtke M, von Grafenstein S, Kirchmair J, Liedl KR, Rollinger JM, Nat Prod Rep 2012 29 11 36 10.1039/c1np00053e 22025274
20. Anti-influenza agents from plants and traditional Chinese medicine. Wang X, Jia W, Zhao A, Wang X, Phytother Res 2006 20 335 341 10.1002/ptr.1892 16619359
21. Structure-activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activities. Liu AL, Wang HD, Lee SM, Wang YT, Du GH, Bioorg Med Chem 2008 16 7141 7147 10.1016/j.bmc.2008.06.049 18640042
22. Biological evaluation of anti-influenza viral activity of semi-synthetic catechin derivatives. Song JM, Park KD, Lee KH, Byun YH, Park JH, Kim SH, Kim JH, Seong BL, Antiviral Res 2007 76 178 185 10.1016/j.antiviral.2007.07.001 17709148 (Pubitemid 47422312)
23. Curcumin induces glutathione biosynthesis and inhibits NF-kappaB activation and interleukin-8 release in alveolar epithelial cells: mechanism of free radical scavenging activity. Biswas SK, McClure D, Jimenez LA, Megson IL, Rahman I, Antioxid Redox Signal 2005 7 32 41 10.1089/ars.2005.7.32 15650394 (Pubitemid 40187923)
24. Identification of cyanidin glycosides as constituents of freeze-dried black raspberries which inhibit anti-benzo[a]pyrene-7,8-diol-9,10-epoxide induced NFkappaB and AP-1 activity. Hecht SS, Huang C, Stoner GD, Li J, Kenney PM, Sturla SJ, Carmella SG, Carcinogenesis 2006 27 1617 1626 16522666 (Pubitemid 44288051)
25. Tea polyphenol epigallocatechin 3-gallate impedes the anti-apoptotic effects of low-grade repetitive stress through inhibition of Akt and NFkappaB survival pathways. Sen P, Chakraborty PK, Raha S, FEBS Lett 2006 580 278 284 10.1016/j.febslet.2005.12.013 16376342 (Pubitemid 43005350)
26. Anti-inflammatory and anti-oxidative effects of the green tea polyphenol epigallocatechin gallate in human corneal epithelial cells. Cavet ME, Harrington KL, Vollmer TR, Ward KW, Zhang JZ, Mol Vis 2011 17 533 542 21364905
27. Biochanin-A, an isoflavon, showed anti-proliferative and anti-inflammatory activities through the inhibition of iNOS expression, p38-MAPK and ATF-2 phosphorylation and blocking NFkappaB nuclear translocation. Kole L, Giri B, Manna SK, Pal B, Ghosh S, Eur J Pharmacol 2011 653 8 15 10.1016/j.ejphar.2010.11.026 21147093
28. Differential antiviral and anti-inflammatory mechanisms of the flavonoids biochanin A and baicalein in H5N1 influenza A virus-infected cells. Sithisarn P, Michaelis M, Schubert-Zsilavecz M, Cinatl J Jr, Antiviral Res 2013 97 41 48 10.1016/j.antiviral.2012.10.004 23098745
29. Effect of the phosphatidylinositol 3-kinase/Akt pathway on influenza A virus propagation. Shin YK, Liu Q, Tikoo SK, Babiuk LA, Zhou Y, J Gen Virol 2007 88 942 950 10.1099/vir.0.82483-0 17325368 (Pubitemid 46359565)
30. Comparison of pro-inflammatory cytokine expression and cellular signal transduction in human macrophages infected with different influenza A viruses. Geiler J, Michaelis M, Sithisarn P, Cinatl J Jr, Med Microbiol Immunol 2011 200 53 60 10.1007/s00430-010-0173-y 20865277
31. Disruption of virus-host cell interactions and cell signaling pathways as an anti-viral approach against influenza virus infections. Ludwig S, Biol Chem 2011 392 837 847 21823902
32. Inhibition of influenza virus-induced NF-kappaB and Raf/MEK/ERK activation can reduce both virus titers and cytokine expression simultaneously in vitro and in vivo. Pinto R, Herold S, Cakarova L, Hoegner K, Lohmeyer J, Planz O, Pleschka S, Antiviral Res 2011 92 45 56 10.1016/j.antiviral.2011.05.009 21641936
33. A prooxidant mechanism for the anticancer and chemopreventive properties of plant polyphenols. Khan HY, Zubair H, Ullah MF, Ahmad A, Hadi SM, Curr Drug Targets 2012 13 1738 1749 10.2174/138945012804545560 23140285
34. Suppressing production of reactive oxygen species (ROS) for influenza A virus therapy. Vlahos R, Stambas J, Selemidis S, Trends Pharmacol Sci 2012 33 3 8 10.1016/j.tips.2011.09.001 21962460
35. N-acetyl-L-cysteine (NAC) inhibits virus replication and expression of pro-inflammatory molecules in A549 cells infected with highly pathogenic H5N1 influenza A virus. Geiler J, Michaelis M, Naczk P, Leutz A, Langer K, Doerr HW, Cinatl J Jr, Biochem Pharmacol 2010 79 413 420 10.1016/j.bcp.2009.08.025 19732754
36. Glycyrrhizin exerts antioxidative effects in H5N1 influenza A virus-infected cells and inhibits virus replication and pro-inflammatory gene expression. Michaelis M, Geiler J, Naczk P, Sithisarn P, Leutz A, Doerr HW, Cinatl J Jr, PLoS One 2011 6 19705 10.1371/journal.pone.0019705 21611183